Robert L. Little
2007
In 2007, Robert L. Little earned a total compensation of $434K as Vice President and Chief Commercial Officer at Halozyme Therapeutics, a 122% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $76,100 |
|---|---|
| Option Awards | $50,178 |
| Salary | $307,400 |
| Other | $351 |
| Total | $434,029 |
Little received $307.4K in salary, accounting for 71% of the total pay in 2007.
Little also received $76.1K in non-equity incentive plan, $50.2K in option awards and $351 in other compensation.
Rankings
In 2007, Robert L. Little's compensation ranked 6,494th out of 8,700 executives tracked by ExecPay. In other words, Little earned more than 25.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,494 out of 8,700 | 25th |
Division Manufacturing | 2,486 out of 3,314 | 25th |
Major group Chemicals And Allied Products | 560 out of 746 | 25th |
Industry group Drugs | 394 out of 546 | 28th |
Industry Biological Products, Except Diagnostic Substances | 76 out of 118 | 36th |
Source: SEC filing on April 1, 2010.
Little's colleagues
We found five more compensation records of executives who worked with Robert L. Little at Halozyme Therapeutics in 2007.
2007
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2007
William Fallon
Halozyme Therapeutics
Vice President Manufacturing and Operations
2007
Richard Yocum
Halozyme Therapeutics
Vice President — Clinical Development and Medical Affairs
2007
Gregory Frost
Halozyme Therapeutics
Chief Scientific Officer
2007
David Ramsay
Halozyme Therapeutics